Cargando…

Long-Term Effectiveness and Safety of SGLT-2 Inhibitors in an Italian Cohort of Patients with Type 2 Diabetes Mellitus

BACKGROUND: SGLT-2 (sodium-glucose cotransporter-2) inhibitors are a novel class of oral hypoglycemic agents for the management of type 2 diabetes mellitus (T2DM). Herein, we aimed to assess the long-term effectiveness and safety of SGLT-2 inhibitors in a Southern Italy population of subjects affect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mirabelli, Maria, Chiefari, Eusebio, Caroleo, Patrizia, Vero, Raffaella, Brunetti, Francesco Saverio, Corigliano, Domenica Maria, Arcidiacono, Biagio, Foti, Daniela Patrizia, Puccio, Luigi, Brunetti, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875368/ https://www.ncbi.nlm.nih.gov/pubmed/31781664 http://dx.doi.org/10.1155/2019/3971060

Ejemplares similares

Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes
por: Mirabelli, Maria, et al.
Publicado: (2019)

First Trimester Combined Test (FTCT) as a Predictor of Gestational Diabetes Mellitus
por: Visconti, Federica, et al.
Publicado: (2019)

Predictors of Postpartum Glucose Tolerance Testing in Italian Women with Gestational Diabetes Mellitus
por: Capula, Carmelo, et al.
Publicado: (2013)

Gestational Diabetes Mellitus: Screening and Outcomes in Southern Italian Pregnant Women
por: Capula, Carmelo, et al.
Publicado: (2013)

Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases
por: Mirabelli, Maria, et al.
Publicado: (2020)

Appropriate Timing of Gestational Diabetes Mellitus Diagnosis in Medium- and Low-Risk Women: Effectiveness of the Italian NHS Recommendations in Preventing Fetal Macrosomia
por: Quaresima, Paola, et al.
Publicado: (2020)

Potential Benefits and Harms of Novel Antidiabetic Drugs during COVID-19 Crisis
por: Mirabelli, Maria, et al.
Publicado: (2020)

Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
por: Mirabelli, Maria, et al.
Publicado: (2021)

Barriers to Postpartum Glucose Intolerance Screening in an Italian Population
por: Quaresima, Paola, et al.
Publicado: (2018)

Cross-talk among HMGA1 and FoxO1 in control of nuclear insulin signaling
por: Chiefari, Eusebio, et al.
Publicado: (2018)

Long-Term Effectiveness and Safety of Once Weekly Dulaglutide as Add-on to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
por: Mirabelli, Maria, et al.
Publicado: (2021)

Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links
por: De Rosa, Salvatore, et al.
Publicado: (2018)

Maternal Preconception Body Mass Index Overtakes Age as a Risk Factor for Gestational Diabetes Mellitus
por: Mirabelli, Maria, et al.
Publicado: (2023)

Cooperation between HMGA1, PDX-1, and MafA is Essential for Glucose-Induced Insulin Transcription in Pancreatic Beta Cells
por: Arcidiacono, Biagio, et al.
Publicado: (2015)

MicroRNA-1281 as a Novel Circulating Biomarker in Patients With Diabetic Retinopathy
por: Greco, Marta, et al.
Publicado: (2020)

HMGA1 is a novel transcriptional regulator of the FoxO1 gene
por: Arcidiacono, Biagio, et al.
Publicado: (2017)

Obesity-related hypoxia via miR-128 decreases insulin-receptor expression in human and mouse adipose tissue promoting systemic insulin resistance
por: Arcidiacono, Biagio, et al.
Publicado: (2020)

Early Onset Acceleration of Fetal Growth in Gestational Diabetes Mellitus: Deciding About When and Whom to Screen for Preventing Fetal Macrosomia
por: Mirabelli, Maria, et al.
Publicado: (2021)

Brain-Behavior-Immune Interaction: Serum Cytokines and Growth Factors in Patients with Eating Disorders at Extremes of the Body Mass Index (BMI) Spectrum
por: Caroleo, Mariarita, et al.
Publicado: (2019)

Transcriptional Regulation of the HMGA1 Gene by Octamer-Binding Proteins Oct-1 and Oct-2
por: Chiefari, Eusebio, et al.
Publicado: (2013)

Insulin Resistance and Cancer: In Search for a Causal Link
por: Chiefari, Eusebio, et al.
Publicado: (2021)

Metformin in Gestational Diabetes Mellitus: To Use or Not to Use, That Is the Question
por: Tocci, Vera, et al.
Publicado: (2023)

From Euglycemia to Recent Onset of Type 2 Diabetes Mellitus: A Proof-of-Concept Study on Circulating microRNA Profiling Reveals Distinct, and Early microRNA Signatures
por: Greco, Marta, et al.
Publicado: (2023)

Transcriptional Regulation of Glucose Metabolism: The Emerging Role of the HMGA1 Chromatin Factor
por: Chiefari, Eusebio, et al.
Publicado: (2018)

Insulin Resistance and Cancer Risk: An Overview of the Pathogenetic Mechanisms
por: Arcidiacono, Biagio, et al.
Publicado: (2012)

Editorial: Transcriptional Regulation of Glucose Metabolism: Gaps and Controversies
por: Brunetti, Antonio, et al.
Publicado: (2019)

Expression of matrix metalloproteinase-11 is increased under conditions of insulin resistance
por: Arcidiacono, Biagio, et al.
Publicado: (2017)

Does NUCB2/Nesfatin-1 Influence Eating Behaviors in Obese Patients with Binge Eating Disorder? Toward a Neurobiological Pathway
por: Caroleo, Mariarita, et al.
Publicado: (2023)

A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression
por: Chiefari, Eusebio, et al.
Publicado: (2016)

Awareness of gestational diabetes mellitus foetal-maternal risks: an Italian cohort study on pregnant women
por: Quaresima, Paola, et al.
Publicado: (2021)

Cooperation between HMGA1 and HIF-1 Contributes to Hypoxia-Induced VEGF and Visfatin Gene Expression in 3T3-L1 Adipocytes
por: Messineo, Sebastiano, et al.
Publicado: (2016)

A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components
por: Chiefari, Eusebio, et al.
Publicado: (2013)

The Association between HMGA1 rs146052672 Variant and Type 2 Diabetes: A Transethnic Meta-Analysis
por: Bianco, Aida, et al.
Publicado: (2015)

HMGA1 is a novel downstream nuclear target of the insulin receptor signaling pathway
por: Chiefari, Eusebio, et al.
Publicado: (2012)

Insulin and osteocalcin: further evidence for a mutual cross-talk
por: Bilotta, Francesco L., et al.
Publicado: (2017)

Correction to: Insulin and osteocalcin: further evidence for a mutual cross-talk
por: Bilotta, Francesco L., et al.
Publicado: (2017)

New Target Genes for the Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Antitumour Activity: Perspectives from the Insulin Receptor
por: Foti, Daniela P., et al.
Publicado: (2009)

The anticancer effects of Metformin in the male germ tumor SEM-1 cell line are mediated by HMGA1
por: Salatino, Alessandro, et al.
Publicado: (2022)

Comment on: Marquez et al. Low-Frequency Variants in HMGA1 Are Not Associated With Type 2 Diabetes Risk. Diabetes 2012;61:524–530
por: Brunetti, Antonio, et al.
Publicado: (2012)

A novel mechanism of post-translational modulation of HMGA functions by the histone chaperone nucleophosmin
por: Arnoldo, Laura, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3h0rtf4fatef1j88cqj0cvipkl